Skip to content

Electrostimulation Program for Lung Transplant Recipients in the ICU

Effect of an Electrostimulation Program in Lung Transplant Recipients During Their Stay in the Intensive Critical Care Unit. Experimental Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05410522
Enrollment
58
Registered
2022-06-08
Start date
2022-05-09
Completion date
2024-06-30
Last updated
2022-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Transplantation

Brief summary

This study aims to evaluate rectus femoris muscle mass in lung transplant recipients and the effect of a training program during ICU admission based on the use of electrical muscle stimulation (EMS)

Detailed description

Lung transplantation is so far the only viable therapy for those individuals with a life-threatening chronic respiratory individuals with a chronic respiratory problem that compromises their life in a period of less than two years and the therapeutic options have been exhausted. The investigators are dealing with individuals with a prolonged disease process, characterized mainly by the reduction of their respiratory capacities, which has a great impact on the basic activities of daily living. Pulmonary involvement conditions the mobility of the individual, limiting physical activity and leading to episodes of dyspnea. The aerobic capacity of the patient is very impaired before the transplant, although after the transplant, it continues in levels below normal for their age . This, resulting in episodes of dyspnea impacts on the extraction and utilization of muscular oxygen , which reduces mobility periods. Limitations in physical activity and even mobility prior to physical activity and even mobility limitations prior to transplantation lead these individuals to marked muscular deterioration, which has an impact on both the general physical and psychological levels. The aim of this study is assessment of muscle status in transplant recipients in lung transplant recipients after application of EMS therapy in the ICU.The sample is divided into two groups, a control group that will not receive EMS therapy and a control group that receive it.

Interventions

DEVICEEMS Program

Lower limb electrostimulation therapy is scheduled for lung transplant patients. The therapy consists in the application of 2 daily 30-minute sessions that begin in the first 48 hours post-transplantation and are maintained daily until discharge from the hospital.

Sponsors

Hospital Universitario 12 de Octubre
CollaboratorOTHER
Universidad Complutense de Madrid
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Admitted to the lung transplant list according to the criteria of the Health System. * Those who attend the rehabilitation consultation of the hospital under study to undergo treatment prior to transplantation. * They must receive the graft at the hospital under study and be admitted to the resuscitation unit at the same center for post-surgical follow-up.

Exclusion criteria

* Those who are rejected from the transplant list or deceased before the implant is performed. * Lack of follow-up by the rehabilitation consultation. * Are receiving treatment with muscle relaxants after admission to the ICU. * Present skin alterations incompatible with EMS. * Contraindications to perform the transplant proposed according to the criteria of the Health System.

Design outcomes

Primary

MeasureTime frameDescription
Variation of muscle mass in the quadricepsUp to 6 months prior to transplantation, within 24 hours of admission and every seven days and/or until discharge from the ICU (up to 14 days).The quadriceps muscle mass of the lung transplant recipient will be measured prior to transplantation and will be monitored in the first 24 hours post-transplant and every 7 days from admission until hospital discharge.

Secondary

MeasureTime frameDescription
Mobility assessment according to ICU-Mobility scale (IMS)Each day in the morning and afternoon, until discharge from ICU (up to 14 days).Ability to move during ICU admission. IMS is a scale containing 10 items ranging from 0 (no mobility at all) to 10 (walks unaided), which some authors have categorized binary (\< 4 passive/active mobilization in bed and ≥ 4 active mobilization out of bed).
Leg strength according to Chair and Stand testUp to 6 months prior to transplantation and at ICU discharge (up to 14 days)Leg strength assessment before transplantation and at discharge from ICU (up to 14 days), using Chair and Stand test

Countries

Spain

Contacts

Primary ContactIgnacio Zaragoza García, PhD
izaragoz@ucm.es+34913941346

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026